Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Nkgen Biotech Inc NKGN

Healthcare Biotechnology
NKGen Biotech, Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapeutics. Its product candidates are based on a manufacturing and cryopreservation process, which produces SuperNK (SNK) cells. SNK cells can be produced in large quantities and cryopreserved, while... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:NKGN)

NKGen Biotech Receives Notifications From Nasdaq Related to Delayed Quarterly Report and Decision of the Nasdaq Hearings Panel

GlobeNewswire 2 days ago

NKGen Biotech Presents Phase 1/2a Troculeucel Data in Alzheimer's Disease at the 17th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference

GlobeNewswire October 29, 2024

NKGen Biotech Announces Upcoming Presentation at the 16th World Stroke Congress (WSC 2024)

GlobeNewswire October 15, 2024

NKGen Biotech Announces Poster Presentations at the 17th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference

GlobeNewswire October 8, 2024

NKGen Biotech's Positive Phase 1 Clinical Data in Moderate Alzheimer's Disease Advances Troculeucel into Phase 2 with First Patient Dosed in Phase 1/2a Trial

GlobeNewswire September 12, 2024

NKGen Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire September 3, 2024

NKGen Biotech Receives Notification From Nasdaq Related to Delayed Quarterly Report

GlobeNewswire August 22, 2024

NKGen Biotech Presents New Positive SNK01 Biomarker Data at the 2024 Alzheimer's Association International Conference

GlobeNewswire July 30, 2024

NKGen Biotech to Present New Positive SNK01 Clinical Trial Biomarker Data at the 2024 Alzheimer's Association International Conference

GlobeNewswire July 18, 2024
View More News ››

Opinion & Analysis (NDAQ:NKGN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:NKGN)

NKGN....N.L.O.D $1.02

Go figure....skating ! Waiting for the P.O announcement
Iseneschal - July 18, 2024

RE:NKGN....early a.m runner on NR....Caveat Emptor imho ; )

Can't say I didn't warn you.....now at $1.06 n.l.o.d All the Chasers are roasted again !!!!
Iseneschal - July 18, 2024

NKGN....early a.m runner on NR....Caveat Emptor imho ; )

Be a chaser and your going to get your face ripped off....P.O set up!!! https://www.sec.gov/Archives/edgar/data/1845459...
Iseneschal - July 18, 2024

Excellent ceo interview from NKGen!

https://youtu.be/g1qwPyAV8mM?si=Ip-B1KxPEzgncEWX
BryceCanada - November 7, 2023
View more Bullboard ››

Indiva Ltd

Indiva Ltd

Indiva Limited, through its indirect wholly owned subsidiary, Indiva Inc., is a Canada-based producer of cannabis servicing ...
View More »